MSCopilot, a new Multiple Sclerosis self-assessment digital solution: results of a comparative study versus standard tests.
Fiche publication
Date publication
septembre 2019
Journal
European journal of neurology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Maillart E, Labauge P, Cohen M, Maarouf A, Vukusic S, Donzé C, Gallien P, De Sèze J, Bourre B, Moreau T, Louapre C, Mayran P, Bieuvelet S, Vallée M, Bertillot F, Klaeylé L, Argoud AL, Zinaï S, Tourbah A
Lien Pubmed
Résumé
Assessing patients' disability in multiple sclerosis (MS) requires time-consuming batteries of hospital tests. MSCopilot is a software medical device for the self-assessment of patients with MS (PwMS), combining 4 tests: walking, dexterity, cognition, and low contrast vision. The objective was to validate MSCopilot versus Multiple Sclerosis Functional Composite (MSFC).
Mots clés
Health information technology, Mobile application, Multiple Sclerosis Functional Composite (MSFC), Multiple sclerosis, Reliability, Smartphone app, Validity, eHealth
Référence
Eur. J. Neurol.. 2019 Sep 20;: